39
views
0
recommends
+1 Recommend
0 collections
    1
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor.

          Related collections

          Author and article information

          Journal
          JAMA
          JAMA
          American Medical Association (AMA)
          1538-3598
          0098-7484
          Jul 14 2004
          : 292
          : 2
          Affiliations
          [1 ] Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Md 21287, USA. jgallant@jhmi.edu
          Article
          292/2/191
          10.1001/jama.292.2.191
          15249568
          b14a199e-08c9-4a64-895f-97fb79c2dd8c
          History

          Comments

          Comment on this article